Paper7712484
Detection and cloning of a common region of loss of heterozygosity at chromosome 1p in breast cancer.
Nagai H and 6 others. Cancer Res, 1995. Cited by 111 papers, by iCite.
Cite this record
ConductScience Library. Detection and cloning of a common region of loss of heterozygosity at chromosome 1p in breast cancer. Papers, record 7712484. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7712484
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Detection and cloning of a common region of loss of heterozygosity at chromosome 1p in breast cancer.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Breast Neoplasms | Major topic |
| Chromosome Deletion | Major topic |
| Chromosomes, Human, Pair 1 | Major topic |
| Base Sequence | |
| Breast | |
| Chromosome Mapping | |
| Chromosomes, Artificial, Yeast | |
| Cloning, Molecular | |
| DNA Primers | |
| Female | |
| Genetic Markers | |
| Humans | |
| Molecular Sequence Data | |
| Polymerase Chain Reaction | |
| Repetitive Sequences, Nucleic Acid |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| CA39860 | NCI NIH HHS | United States | R35CA039860 | PubMed and NIH |
Source NIH RePORTER
Cited by28
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 111 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40777951 | MiRNA-153 attenuates progression of non-small cell lung cancer through targeting positive regulatory/SET domain 2. | Afr Health Sci | 2024 | https://conductscience.org/library/papers/40777951 | PubMed |
| 37509331 | SELENOF Controls Proliferation and Cell Death in Breast-Derived Immortalized and Cancer Cells. | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/37509331 | PubMed |
| 36979420 | Distinct Roles of SELENOF in Different Human Cancers. | Biomolecules | 2023 | https://conductscience.org/library/papers/36979420 | PubMed |
| 34508103 | Circadian PERformance in breast cancer: a germline and somatic genetic study of PER3VNTR polymorphisms and gene co-expression. | NPJ Breast Cancer | 2021 | https://conductscience.org/library/papers/34508103 | PubMed |
| 31243265 | LINC01355 suppresses breast cancer growth through FOXO3-mediated transcriptional repression of CCND1. | Cell Death Dis | 2019 | https://conductscience.org/library/papers/31243265 | PubMed |
| 26391647 | Integrating genetics and epigenetics in breast cancer: biological insights, experimental, computational methods and therapeutic potential. | BMC Syst Biol | 2015 | https://conductscience.org/library/papers/26391647 | PubMed |
| 25032850 | MicroRNA-34a: a potential therapeutic target in human cancer. | Cell Death Dis | 2014 | https://conductscience.org/library/papers/25032850 | PubMed |
| 24940000 | tRNA synthetase counteracts c-Myc to develop functional vasculature. | Elife | 2014 | https://conductscience.org/library/papers/24940000 | PubMed |
| 24120991 | The tumor suppressor Chd5 is induced during neuronal differentiation in the developing mouse brain. | Gene Expr Patterns | 2013 | https://conductscience.org/library/papers/24120991 | PubMed |
| 23001043 | MicroRNA-34 suppresses breast cancer invasion and metastasis by directly targeting Fra-1. | Oncogene | 2013 | https://conductscience.org/library/papers/23001043 | PubMed |
| 22363487 | Hypoxia-induced down-regulation of microRNA-34a promotes EMT by targeting the Notch signaling pathway in tubular epithelial cells. | PLoS One | 2012 | https://conductscience.org/library/papers/22363487 | PubMed |
| 22102859 | MiR-34a expression has an effect for lower risk of metastasis and associates with expression patterns predicting clinical outcome in breast cancer. | PLoS One | 2011 | https://conductscience.org/library/papers/22102859 | PubMed |
| 21367844 | Histone deacetylase inhibitors upregulate Rap1GAP and inhibit Rap activity in thyroid tumor cells. | Endocr Relat Cancer | 2011 | https://conductscience.org/library/papers/21367844 | PubMed |
| 20439492 | Downregulation of Rap1GAP in human tumor cells alters cell/matrix and cell/cell adhesion. | Mol Cell Biol | 2010 | https://conductscience.org/library/papers/20439492 | PubMed |
| 19066305 | Loss of Rap1GAP in papillary thyroid cancer. | J Clin Endocrinol Metab | 2009 | https://conductscience.org/library/papers/19066305 | PubMed |
| 19047905 | DNA hypermethylation profiles in squamous cell carcinoma of the vulva. | Int J Gynecol Pathol | 2009 | https://conductscience.org/library/papers/19047905 | PubMed |
| 17646383 | Downregulation of Rap1GAP contributes to Ras transformation. | Mol Cell Biol | 2007 | https://conductscience.org/library/papers/17646383 | PubMed |
| 14973555 | CLCA2 tumour suppressor gene in 1p31 is epigenetically regulated in breast cancer. | Oncogene | 2004 | https://conductscience.org/library/papers/14973555 | PubMed |
| 13680524 | Pooled analysis of loss of heterozygosity in breast cancer: a genome scan provides comparative evidence for multiple tumor suppressors and identifies novel candidate regions. | Am J Hum Genet | 2003 | https://conductscience.org/library/papers/13680524 | PubMed |
| 11986397 | Molecular aspects of melanocytic dysplastic nevi. | J Mol Diagn | 2002 | https://conductscience.org/library/papers/11986397 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/7712484
GET https://conductscience.org/api/papers/v1/7712484/cited_by?page=2